Show simple item record

dc.contributor.authorUnger, Wendy Wj
dc.contributor.authorMayer, Christian T
dc.contributor.authorEngels, Steef
dc.contributor.authorHesse, Christina
dc.contributor.authorPerdicchio, Maurizio
dc.contributor.authorPuttur, Franz
dc.contributor.authorStreng-Ouwehand, Ingeborg
dc.contributor.authorLitjens, Manja
dc.contributor.authorKalay, Hakan
dc.contributor.authorBerod, Luciana
dc.contributor.authorSparwasser, Tim
dc.contributor.authorvan Kooyk, Yvette
dc.date.accessioned2015-10-16T13:04:19Zen
dc.date.available2015-10-16T13:04:19Zen
dc.date.issued2015-08en
dc.identifier.citationAntigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression. 2015, 4 (8):e970462 Oncoimmunologyen
dc.identifier.issn2162-4011en
dc.identifier.pmid26405564en
dc.identifier.doi10.4161/21624011.2014.970462en
dc.identifier.urihttp://hdl.handle.net/10033/579795en
dc.description.abstractTherapeutic vaccinations against cancer are still largely ineffective. Major caveats are inefficient delivery of tumor antigens to dendritic cells (DCs) and excessive immune suppression by Foxp3(+) regulatory T cells (Tregs), resulting in defective T cell priming and failure to induce tumor regression. To circumvent these problems we evaluated a novel combinatorial therapeutic strategy. We show that tumor antigen targeting to DC-SIGN in humanized hSIGN mice via glycans or specific antibodies induces superior T cell priming. Next, this targeted therapy was combined with transient Foxp3(+) Treg depletion employing hSIGNxDEREG mice. While Treg depletion alone slightly delayed B16-OVA melanoma growth, only the combination therapy instigated long-term tumor regression in a substantial fraction of mice. This novel strategy resulted in optimal generation of antigen-specific activated CD8(+) T cells which accumulated in regressing tumors. Notably, Treg depletion also allowed the local appearance of effector T cells specific for endogenous B16 antigens. This indicates that antitumor immune responses can be broadened by therapies aimed at controlling Tregs in tumor environments. Thus, transient inhibition of Treg-mediated immune suppression potentiates DC targeted antigen vaccination and tumor-specific immunity.
dc.languageENGen
dc.titleAntigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression.en
dc.typeArticleen
dc.contributor.departmentInstitute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.en
dc.identifier.journalOncoimmunologyen
refterms.dateFOA2018-06-13T00:44:24Z
html.description.abstractTherapeutic vaccinations against cancer are still largely ineffective. Major caveats are inefficient delivery of tumor antigens to dendritic cells (DCs) and excessive immune suppression by Foxp3(+) regulatory T cells (Tregs), resulting in defective T cell priming and failure to induce tumor regression. To circumvent these problems we evaluated a novel combinatorial therapeutic strategy. We show that tumor antigen targeting to DC-SIGN in humanized hSIGN mice via glycans or specific antibodies induces superior T cell priming. Next, this targeted therapy was combined with transient Foxp3(+) Treg depletion employing hSIGNxDEREG mice. While Treg depletion alone slightly delayed B16-OVA melanoma growth, only the combination therapy instigated long-term tumor regression in a substantial fraction of mice. This novel strategy resulted in optimal generation of antigen-specific activated CD8(+) T cells which accumulated in regressing tumors. Notably, Treg depletion also allowed the local appearance of effector T cells specific for endogenous B16 antigens. This indicates that antitumor immune responses can be broadened by therapies aimed at controlling Tregs in tumor environments. Thus, transient inhibition of Treg-mediated immune suppression potentiates DC targeted antigen vaccination and tumor-specific immunity.


Files in this item

Thumbnail
Name:
Unger et al_final.pdf
Size:
1.043Mb
Format:
PDF
Description:
Open Access article

This item appears in the following Collection(s)

Show simple item record